Crisis deepens at the US Food and Drug Administration.
Lenzer
Jeanne
J
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D017277:Drug Approval; D007783:Lactones / Q000009:adverse effects*; D013450:Sulfones; D014481:United States; D014486:United States Food and Drug Administration; D035642:Whistleblowing
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib